Chronic Kidney Disease (CKD) is a widespread and frequently under recognised condition impacting millions around the globe. With an ageing population, the prevalence of CKD is projected to rise ...

Hebrew University researchers test paricalcitol for treating CKD in dogs, showing promise against proteinuria. Study ...

A new study led by Dr. Hilla Chen from the Koret School of Veterinary Medicine at Hebrew University, recently published in ...

Akebia Therapeutics, Inc.’s AKBA share price has dipped by 22.21%, which has investors questioning if this is right time to ...

Clinicians should continue to monitor UACR or UPCR in at-risk children. During periods of rapid growth such as puberty, children with low GFR may show rapid decline in kidney function. Puberty is a ...

Maxim analyst Naz Rahman lowered the firm’s price target on scPharmaceuticals (SCPH) to $12 from $20 but keeps a Buy rating on the shares after ...

Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 million Cash and cash equivalents of $75.7 million as of December 31, 2024 ...

It appears Jaecoo Malaysia is in for a busy year – less than a month after launching the J7 PHEV, the company has revealed that its next model will be the flagship J8, which will ...